# pathway_0089: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0089.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Glycan degradation

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MVSFTTLLTAVATAVSAVTASPLEALKRGIQPGTGVHDGYFYSFWTDGRGYVDFNNGPRGSYRVSWSNVNNWVGGKGWNPGPPRRIAYNGTWNNWNVNSYLALYGWTTNPLVEYYIVEAYGSYNPSSGAARLGTIEDDGGVYDIYRTRRINQPSIIGTASFDQYWSVRRQKRVGGTIDTGKHFDEWRRQGNLQLGAWNYMIMATEGYQSSGSAEIEVRSLD

[Multiple Choices]
A. xylan degradation. .
B. Glycan degradation
C. Antifungal biosynthesis. .
D. Pigment biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt entry identifies the protein as endo-1,4-beta-xylanase 11A and annotates both glycan degradation and xylan degradation as pathways. The pathway annotation cites computational RuleBase and PubMed evidence; the cited publication concerns a GH11 xylanase from this fungus and xylan degradation. Thus B is supported, though not uniquely supported over A.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with a secreted carbohydrate-active enzyme, but that broad inference does not establish its specific substrate or distinguish the pathway labels offered.


**Missing item-specific fact**

> The protein-specific identification and substrate/function evidence showing that this sequence encodes xylanase 11A, along with its pathway annotation, are not supplied in the question.


**Reason**

> Choosing a pathway requires protein-specific functional information absent from the input. The sequence alone does not meaningfully distinguish the two carbohydrate-degradation choices, and recognizing the exact protein from a database would be lookup or memorization rather than reasoning from the supplied information.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> The sequence-matched annotation explicitly lists both xylan degradation and glycan degradation. The question gives no criterion for choosing one as the primary pathway, and xylan degradation is also a specific form of glycan degradation.


### Important caveats

- Reviewer-only database evidence supports the key but was not available to the evaluated model.
- The matched annotation includes computational and cited PubMed evidence; the underlying primary study was not independently reviewed here.
- The historical and current records match the supplied sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with a secreted carbohydrate-active enzyme, but that broad inference does not establish its specific substrate or distinguish the pathway labels offered.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification and substrate/function evidence showing that this sequence encodes xylanase 11A, along with its pathway annotation, are not supplied in the question.",
    "reason": "Choosing a pathway requires protein-specific functional information absent from the input. The sequence alone does not meaningfully distinguish the two carbohydrate-degradation choices, and recognizing the exact protein from a database would be lookup or memorization rather than reasoning from the supplied information."
  },
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry identifies the protein as endo-1,4-beta-xylanase 11A and annotates both glycan degradation and xylan degradation as pathways. The pathway annotation cites computational RuleBase and PubMed evidence; the cited publication concerns a GH11 xylanase from this fungus and xylan degradation. Thus B is supported, though not uniquely supported over A."
  },
  "important_caveats": [
    "Reviewer-only database evidence supports the key but was not available to the evaluated model.",
    "The matched annotation includes computational and cited PubMed evidence; the underlying primary study was not independently reviewed here.",
    "The historical and current records match the supplied sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "The sequence-matched annotation explicitly lists both xylan degradation and glycan degradation. The question gives no criterion for choosing one as the primary pathway, and xylan degradation is also a specific form of glycan degradation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry identifies the protein as endo-1,4-beta-xylanase 11A and annotates both glycan degradation and xylan degradation as pathways. The pathway annotation cites computational RuleBase and PubMed evidence; the cited publication concerns a GH11 xylanase from this fungus and xylan degradation. Thus B is supported, though not uniquely supported over A.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with a secreted carbohydrate-active enzyme, but that broad inference does not establish its specific substrate or distinguish the pathway labels offered.",
    "missing_item_specific_fact": "The protein-specific identification and substrate/function evidence showing that this sequence encodes xylanase 11A, along with its pathway annotation, are not supplied in the question.",
    "reason": "Choosing a pathway requires protein-specific functional information absent from the input. The sequence alone does not meaningfully distinguish the two carbohydrate-degradation choices, and recognizing the exact protein from a database would be lookup or memorization rather than reasoning from the supplied information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "The sequence-matched annotation explicitly lists both xylan degradation and glycan degradation. The question gives no criterion for choosing one as the primary pathway, and xylan degradation is also a specific form of glycan degradation."
  },
  "important_caveats": [
    "Reviewer-only database evidence supports the key but was not available to the evaluated model.",
    "The matched annotation includes computational and cited PubMed evidence; the underlying primary study was not independently reviewed here.",
    "The historical and current records match the supplied sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt annotation for V9TS54 (Endo-1,4-beta-xylanase 11A from Humicola insolens) explicitly states 'PATHWAY: Glycan degradation; xylan degradation' (evidence C5, H3). The author's key B ('Glycan degradation') is directly listed as the primary pathway heading in the annotation. However, 'xylan degradation' (option A) is also explicitly listed in the same annotation as a sub-pathway, making both A and B textually present in the source.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could recognize from the sequence (signal peptide, GH11-family motifs, ~221 aa secreted protein from a fungus) that this is a xylanase. General biological knowledge confirms xylan is a glycan (a polysaccharide), so 'glycan degradation' is a valid broader description. However, distinguishing 'Glycan degradation' (B) from 'xylan degradation' (A) as the 'primary' pathway requires knowledge of UniProt's specific pathway taxonomy convention, where the broader category is listed first as the primary heading and the specific sub-pathway follows after a semicolon.


**Missing item-specific fact**

> The UniProt pathway annotation convention that lists 'Glycan degradation' as the primary pathway heading with 'xylan degradation' as a subordinate sub-pathway. Without this database-specific taxonomy convention, a model identifying the protein as a xylanase would more naturally select 'xylan degradation' (A) as the most specific and relevant pathway.


**Reason**

> Biological reasoning identifies the protein as a xylanase degrading xylan (a glycan). Both 'xylan degradation' and 'glycan degradation' are valid biological descriptions. The choice of B over A depends on knowing UniProt's hierarchical pathway naming convention (broader category first as 'primary'), which is an annotation-specific fact rather than a general biological inference.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> The UniProt annotation explicitly lists both 'Glycan degradation' AND 'xylan degradation' in the same PATHWAY comment (C5: 'Glycan degradation; xylan degradation'). Option A ('xylan degradation') is the more specific and arguably more informative pathway for a xylanase, while option B ('Glycan degradation') is the broader category. The question asks for the 'primary' pathway, but the annotation does not clearly designate one as primary over the other beyond ordering convention. A model reasoning from the protein's specific function (xylan hydrolysis) would defensibly select A.


### Important caveats

- Both A and B are explicitly present in the UniProt pathway annotation; the distinction is a taxonomy hierarchy convention, not a factual disagreement.
- The pathway annotation evidence code includes ECO:0000255 (RuleBase, computational inference) and ECO:0000269 (PubMed, experimental), so the annotation has experimental support for the enzyme's function.
- The protein is a GH11 endo-1,4-beta-xylanase (EC 3.2.1.8) with experimental characterization (PubMed 24262572), confirming xylanase activity.
- The author's accession identification was inferred from dataset metadata (reviewer-only), though the sequence match is confirmed.
- Options C (Antifungal biosynthesis) and D (Pigment biosynthesis) are clearly incorrect distractors with no relation to a secreted glycoside hydrolase.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could recognize from the sequence (signal peptide, GH11-family motifs, ~221 aa secreted protein from a fungus) that this is a xylanase. General biological knowledge confirms xylan is a glycan (a polysaccharide), so 'glycan degradation' is a valid broader description. However, distinguishing 'Glycan degradation' (B) from 'xylan degradation' (A) as the 'primary' pathway requires knowledge of UniProt's specific pathway taxonomy convention, where the broader category is listed first as the primary heading and the specific sub-pathway follows after a semicolon.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The UniProt pathway annotation convention that lists 'Glycan degradation' as the primary pathway heading with 'xylan degradation' as a subordinate sub-pathway. Without this database-specific taxonomy convention, a model identifying the protein as a xylanase would more naturally select 'xylan degradation' (A) as the most specific and relevant pathway.",
    "reason": "Biological reasoning identifies the protein as a xylanase degrading xylan (a glycan). Both 'xylan degradation' and 'glycan degradation' are valid biological descriptions. The choice of B over A depends on knowing UniProt's hierarchical pathway naming convention (broader category first as 'primary'), which is an annotation-specific fact rather than a general biological inference."
  },
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "The UniProt annotation for V9TS54 (Endo-1,4-beta-xylanase 11A from Humicola insolens) explicitly states 'PATHWAY: Glycan degradation; xylan degradation' (evidence C5, H3). The author's key B ('Glycan degradation') is directly listed as the primary pathway heading in the annotation. However, 'xylan degradation' (option A) is also explicitly listed in the same annotation as a sub-pathway, making both A and B textually present in the source."
  },
  "important_caveats": [
    "Both A and B are explicitly present in the UniProt pathway annotation; the distinction is a taxonomy hierarchy convention, not a factual disagreement.",
    "The pathway annotation evidence code includes ECO:0000255 (RuleBase, computational inference) and ECO:0000269 (PubMed, experimental), so the annotation has experimental support for the enzyme's function.",
    "The protein is a GH11 endo-1,4-beta-xylanase (EC 3.2.1.8) with experimental characterization (PubMed 24262572), confirming xylanase activity.",
    "The author's accession identification was inferred from dataset metadata (reviewer-only), though the sequence match is confirmed.",
    "Options C (Antifungal biosynthesis) and D (Pigment biosynthesis) are clearly incorrect distractors with no relation to a secreted glycoside hydrolase."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "The UniProt annotation explicitly lists both 'Glycan degradation' AND 'xylan degradation' in the same PATHWAY comment (C5: 'Glycan degradation; xylan degradation'). Option A ('xylan degradation') is the more specific and arguably more informative pathway for a xylanase, while option B ('Glycan degradation') is the broader category. The question asks for the 'primary' pathway, but the annotation does not clearly designate one as primary over the other beyond ordering convention. A model reasoning from the protein's specific function (xylan hydrolysis) would defensibly select A."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt annotation for V9TS54 (Endo-1,4-beta-xylanase 11A from Humicola insolens) explicitly states 'PATHWAY: Glycan degradation; xylan degradation' (evidence C5, H3). The author's key B ('Glycan degradation') is directly listed as the primary pathway heading in the annotation. However, 'xylan degradation' (option A) is also explicitly listed in the same annotation as a sub-pathway, making both A and B textually present in the source.",
    "evidence_ids": ["C5", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could recognize from the sequence (signal peptide, GH11-family motifs, ~221 aa secreted protein from a fungus) that this is a xylanase. General biological knowledge confirms xylan is a glycan (a polysaccharide), so 'glycan degradation' is a valid broader description. However, distinguishing 'Glycan degradation' (B) from 'xylan degradation' (A) as the 'primary' pathway requires knowledge of UniProt's specific pathway taxonomy convention, where the broader category is listed first as the primary heading and the specific sub-pathway follows after a semicolon.",
    "missing_item_specific_fact": "The UniProt pathway annotation convention that lists 'Glycan degradation' as the primary pathway heading with 'xylan degradation' as a subordinate sub-pathway. Without this database-specific taxonomy convention, a model identifying the protein as a xylanase would more naturally select 'xylan degradation' (A) as the most specific and relevant pathway.",
    "reason": "Biological reasoning identifies the protein as a xylanase degrading xylan (a glycan). Both 'xylan degradation' and 'glycan degradation' are valid biological descriptions. The choice of B over A depends on knowing UniProt's hierarchical pathway naming convention (broader category first as 'primary'), which is an annotation-specific fact rather than a general biological inference."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "The UniProt annotation explicitly lists both 'Glycan degradation' AND 'xylan degradation' in the same PATHWAY comment (C5: 'Glycan degradation; xylan degradation'). Option A ('xylan degradation') is the more specific and arguably more informative pathway for a xylanase, while option B ('Glycan degradation') is the broader category. The question asks for the 'primary' pathway, but the annotation does not clearly designate one as primary over the other beyond ordering convention. A model reasoning from the protein's specific function (xylan hydrolysis) would defensibly select A."
  },
  "important_caveats": [
    "Both A and B are explicitly present in the UniProt pathway annotation; the distinction is a taxonomy hierarchy convention, not a factual disagreement.",
    "The pathway annotation evidence code includes ECO:0000255 (RuleBase, computational inference) and ECO:0000269 (PubMed, experimental), so the annotation has experimental support for the enzyme's function.",
    "The protein is a GH11 endo-1,4-beta-xylanase (EC 3.2.1.8) with experimental characterization (PubMed 24262572), confirming xylanase activity.",
    "The author's accession identification was inferred from dataset metadata (reviewer-only), though the sequence match is confirmed.",
    "Options C (Antifungal biosynthesis) and D (Pigment biosynthesis) are clearly incorrect distractors with no relation to a secreted glycoside hydrolase."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched entry identifies the protein as an endo-1,4-beta-xylanase and annotates its pathway as both glycan degradation and xylan degradation. Thus B is scientifically supported, although it is not the only defensible option.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The N-terminal hydrophobic segment is consistent with a secreted fungal enzyme, and the sequence is consistent with a GH11 xylanase. Transferable knowledge that GH11 xylanases hydrolyze xylan supports xylan degradation (A); because xylan is a glycan, it also supports the broader glycan-degradation category (B). These features distinguish both from antifungal and pigment biosynthesis, but do not uniquely select B over A.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A meaningful pathway inference is possible from the sequence and transferable enzyme-family knowledge. The exact target annotation is not needed to distinguish these pathway choices from C and D, but the overlap between A and B prevents a unique choice between them.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Xylan is a glycan, so degradation of xylan is a form of glycan degradation. The sequence-matched annotation explicitly lists both pathways.


### Important caveats

- The reviewer-only source evidence was not part of the original model input.
- The source supports the keyed answer but also directly supports option A; the choices overlap in scope.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The N-terminal hydrophobic segment is consistent with a secreted fungal enzyme, and the sequence is consistent with a GH11 xylanase. Transferable knowledge that GH11 xylanases hydrolyze xylan supports xylan degradation (A); because xylan is a glycan, it also supports the broader glycan-degradation category (B). These features distinguish both from antifungal and pigment biosynthesis, but do not uniquely select B over A.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A meaningful pathway inference is possible from the sequence and transferable enzyme-family knowledge. The exact target annotation is not needed to distinguish these pathway choices from C and D, but the overlap between A and B prevents a unique choice between them."
  },
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched entry identifies the protein as an endo-1,4-beta-xylanase and annotates its pathway as both glycan degradation and xylan degradation. Thus B is scientifically supported, although it is not the only defensible option."
  },
  "important_caveats": [
    "The reviewer-only source evidence was not part of the original model input.",
    "The source supports the keyed answer but also directly supports option A; the choices overlap in scope."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Xylan is a glycan, so degradation of xylan is a form of glycan degradation. The sequence-matched annotation explicitly lists both pathways."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched entry identifies the protein as an endo-1,4-beta-xylanase and annotates its pathway as both glycan degradation and xylan degradation. Thus B is scientifically supported, although it is not the only defensible option.",
    "evidence_ids": ["C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The N-terminal hydrophobic segment is consistent with a secreted fungal enzyme, and the sequence is consistent with a GH11 xylanase. Transferable knowledge that GH11 xylanases hydrolyze xylan supports xylan degradation (A); because xylan is a glycan, it also supports the broader glycan-degradation category (B). These features distinguish both from antifungal and pigment biosynthesis, but do not uniquely select B over A.",
    "missing_item_specific_fact": "",
    "reason": "A meaningful pathway inference is possible from the sequence and transferable enzyme-family knowledge. The exact target annotation is not needed to distinguish these pathway choices from C and D, but the overlap between A and B prevents a unique choice between them."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Xylan is a glycan, so degradation of xylan is a form of glycan degradation. The sequence-matched annotation explicitly lists both pathways."
  },
  "important_caveats": [
    "The reviewer-only source evidence was not part of the original model input.",
    "The source supports the keyed answer but also directly supports option A; the choices overlap in scope."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt pathway annotation for this sequence (V9TS54, Endo-1,4-beta-xylanase 11A, GH11 family) explicitly states 'Glycan degradation; xylan degradation' (evidence C5/H3). In UniProt's hierarchical pathway format, 'Glycan degradation' is the primary (parent) pathway category with 'xylan degradation' as the specific sub-pathway. The author's choice of B (Glycan degradation) as the 'primary metabolic pathway' is consistent with this hierarchical annotation. The EC 3.2.1.8 designation and experimental characterization (PubMed 24262572) confirm glycoside hydrolase activity within the glycan degradation pathway.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence exhibits multiple features diagnostic of a GH11-family glycoside hydrolase: (1) a classic fungal N-terminal secretory signal peptide (MVSFTTLLTAVATAVSAVTASPLEALK) indicating extracellular function; (2) a tryptophan-rich pattern (WNNW, WNNWNVNSY, WNYMIM) characteristic of the GH11 β-jelly-roll fold's substrate-binding cleft; (3) glycine-rich loops and the overall ~221-residue length matching the GH11 domain architecture. From transferable family knowledge, GH11 enzymes are xylanases—glycoside hydrolases that cleave β-1,4-xylosidic bonds in xylan, a plant cell-wall polysaccharide (glycan). Glycoside hydrolases universally function in glycan degradation pathways. This immediately eliminates C (antifungal biosynthesis) and D (pigment biosynthesis), which involve entirely different enzymatic chemistries (e.g., polyketide or non-ribosomal peptide synthetase machinery). Between A and B, the question asks for the 'primary' pathway. In standard pathway database hierarchies (KEGG map00500, UniProt pathway comments), 'Glycan degradation' is the top-level pathway name, while 'xylan degradation' is a sub-process nested within it. Recognizing this convention from general pathway-database knowledge supports selecting B as the 'primary' pathway.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can identify the GH11 xylanase family from sequence composition (signal peptide, Trp/Gly-rich pattern, length), infer glycoside hydrolase function, and apply the standard pathway-hierarchy convention to select 'Glycan degradation' as the primary pathway over the sub-pathway 'xylan degradation.' Options C and D are excluded by the fundamental enzymatic chemistry implied by the sequence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A"
]
```

> The UniProt annotation lists both 'Glycan degradation' and 'xylan degradation' in the same pathway line. A model or annotator interpreting 'primary pathway' as 'the most specific pathway this enzyme participates in' could reasonably select A (xylan degradation) rather than B (glycan degradation). However, the hierarchical convention (parent; child) and the word 'primary' favor B. The ambiguity is mild but present because both terms appear in the same annotation and both are factually correct descriptions of the enzyme's pathway role.


### Important caveats

- The sequence was matched to UniProt V9TS54 (Endo-1,4-beta-xylanase 11A, GH11) with experimental EC 3.2.1.8 assignment from PubMed 24262572.
- The pathway annotation combines a RuleBase computational inference (ECO:0000255) with experimental evidence (ECO:0000269, PubMed 24262572).
- The distinction between A and B hinges on interpreting 'primary pathway' as the top-level hierarchical category versus the most specific sub-pathway; the question wording slightly favors B but does not fully exclude A.
- The reviewer-only accession and organism identity were not available to the evaluated model; the sequence-based reasoning relies solely on recognizable GH11 family features and general pathway-hierarchy conventions.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence exhibits multiple features diagnostic of a GH11-family glycoside hydrolase: (1) a classic fungal N-terminal secretory signal peptide (MVSFTTLLTAVATAVSAVTASPLEALK) indicating extracellular function; (2) a tryptophan-rich pattern (WNNW, WNNWNVNSY, WNYMIM) characteristic of the GH11 β-jelly-roll fold's substrate-binding cleft; (3) glycine-rich loops and the overall ~221-residue length matching the GH11 domain architecture. From transferable family knowledge, GH11 enzymes are xylanases—glycoside hydrolases that cleave β-1,4-xylosidic bonds in xylan, a plant cell-wall polysaccharide (glycan). Glycoside hydrolases universally function in glycan degradation pathways. This immediately eliminates C (antifungal biosynthesis) and D (pigment biosynthesis), which involve entirely different enzymatic chemistries (e.g., polyketide or non-ribosomal peptide synthetase machinery). Between A and B, the question asks for the 'primary' pathway. In standard pathway database hierarchies (KEGG map00500, UniProt pathway comments), 'Glycan degradation' is the top-level pathway name, while 'xylan degradation' is a sub-process nested within it. Recognizing this convention from general pathway-database knowledge supports selecting B as the 'primary' pathway.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can identify the GH11 xylanase family from sequence composition (signal peptide, Trp/Gly-rich pattern, length), infer glycoside hydrolase function, and apply the standard pathway-hierarchy convention to select 'Glycan degradation' as the primary pathway over the sub-pathway 'xylan degradation.' Options C and D are excluded by the fundamental enzymatic chemistry implied by the sequence."
  },
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt pathway annotation for this sequence (V9TS54, Endo-1,4-beta-xylanase 11A, GH11 family) explicitly states 'Glycan degradation; xylan degradation' (evidence C5/H3). In UniProt's hierarchical pathway format, 'Glycan degradation' is the primary (parent) pathway category with 'xylan degradation' as the specific sub-pathway. The author's choice of B (Glycan degradation) as the 'primary metabolic pathway' is consistent with this hierarchical annotation. The EC 3.2.1.8 designation and experimental characterization (PubMed 24262572) confirm glycoside hydrolase activity within the glycan degradation pathway."
  },
  "important_caveats": [
    "The sequence was matched to UniProt V9TS54 (Endo-1,4-beta-xylanase 11A, GH11) with experimental EC 3.2.1.8 assignment from PubMed 24262572.",
    "The pathway annotation combines a RuleBase computational inference (ECO:0000255) with experimental evidence (ECO:0000269, PubMed 24262572).",
    "The distinction between A and B hinges on interpreting 'primary pathway' as the top-level hierarchical category versus the most specific sub-pathway; the question wording slightly favors B but does not fully exclude A.",
    "The reviewer-only accession and organism identity were not available to the evaluated model; the sequence-based reasoning relies solely on recognizable GH11 family features and general pathway-hierarchy conventions."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A"
    ],
    "reason": "The UniProt annotation lists both 'Glycan degradation' and 'xylan degradation' in the same pathway line. A model or annotator interpreting 'primary pathway' as 'the most specific pathway this enzyme participates in' could reasonably select A (xylan degradation) rather than B (glycan degradation). However, the hierarchical convention (parent; child) and the word 'primary' favor B. The ambiguity is mild but present because both terms appear in the same annotation and both are factually correct descriptions of the enzyme's pathway role."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0089",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt pathway annotation for this sequence (V9TS54, Endo-1,4-beta-xylanase 11A, GH11 family) explicitly states 'Glycan degradation; xylan degradation' (evidence C5/H3). In UniProt's hierarchical pathway format, 'Glycan degradation' is the primary (parent) pathway category with 'xylan degradation' as the specific sub-pathway. The author's choice of B (Glycan degradation) as the 'primary metabolic pathway' is consistent with this hierarchical annotation. The EC 3.2.1.8 designation and experimental characterization (PubMed 24262572) confirm glycoside hydrolase activity within the glycan degradation pathway.",
    "evidence_ids": ["C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence exhibits multiple features diagnostic of a GH11-family glycoside hydrolase: (1) a classic fungal N-terminal secretory signal peptide (MVSFTTLLTAVATAVSAVTASPLEALK) indicating extracellular function; (2) a tryptophan-rich pattern (WNNW, WNNWNVNSY, WNYMIM) characteristic of the GH11 β-jelly-roll fold's substrate-binding cleft; (3) glycine-rich loops and the overall ~221-residue length matching the GH11 domain architecture. From transferable family knowledge, GH11 enzymes are xylanases—glycoside hydrolases that cleave β-1,4-xylosidic bonds in xylan, a plant cell-wall polysaccharide (glycan). Glycoside hydrolases universally function in glycan degradation pathways. This immediately eliminates C (antifungal biosynthesis) and D (pigment biosynthesis), which involve entirely different enzymatic chemistries (e.g., polyketide or non-ribosomal peptide synthetase machinery). Between A and B, the question asks for the 'primary' pathway. In standard pathway database hierarchies (KEGG map00500, UniProt pathway comments), 'Glycan degradation' is the top-level pathway name, while 'xylan degradation' is a sub-process nested within it. Recognizing this convention from general pathway-database knowledge supports selecting B as the 'primary' pathway.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can identify the GH11 xylanase family from sequence composition (signal peptide, Trp/Gly-rich pattern, length), infer glycoside hydrolase function, and apply the standard pathway-hierarchy convention to select 'Glycan degradation' as the primary pathway over the sub-pathway 'xylan degradation.' Options C and D are excluded by the fundamental enzymatic chemistry implied by the sequence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A"],
    "reason": "The UniProt annotation lists both 'Glycan degradation' and 'xylan degradation' in the same pathway line. A model or annotator interpreting 'primary pathway' as 'the most specific pathway this enzyme participates in' could reasonably select A (xylan degradation) rather than B (glycan degradation). However, the hierarchical convention (parent; child) and the word 'primary' favor B. The ambiguity is mild but present because both terms appear in the same annotation and both are factually correct descriptions of the enzyme's pathway role."
  },
  "important_caveats": [
    "The sequence was matched to UniProt V9TS54 (Endo-1,4-beta-xylanase 11A, GH11) with experimental EC 3.2.1.8 assignment from PubMed 24262572.",
    "The pathway annotation combines a RuleBase computational inference (ECO:0000255) with experimental evidence (ECO:0000269, PubMed 24262572).",
    "The distinction between A and B hinges on interpreting 'primary pathway' as the top-level hierarchical category versus the most specific sub-pathway; the question wording slightly favors B but does not fully exclude A.",
    "The reviewer-only accession and organism identity were not available to the evaluated model; the sequence-based reasoning relies solely on recognizable GH11 family features and general pathway-hierarchy conventions."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "V9TS54",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "6e283cc779810dd9174f1b61924b8c74d0bd81ae7161f1184006352195efc500",
  "benchmark_sequence_length": 221,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 41,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2014-03-19",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e",
  "current_source_sequence_sha256": "6e283cc779810dd9174f1b61924b8c74d0bd81ae7161f1184006352195efc500",
  "current_source_sequence_length": 221,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 39,
  "selected_historical_version": {
    "accession": "V9TS54",
    "database": "Swiss-Prot",
    "entryVersion": 39,
    "firstRelease": "2025_03/2025_03",
    "firstReleaseDate": "18-Jun-2025",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "XY11A_HUMIN",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "a074e123d2ec0589aa06f4931d85860d82aaf183072ecb88102fc2c6e967dd34",
  "selected_historical_source_sequence_sha256": "6e283cc779810dd9174f1b61924b8c74d0bd81ae7161f1184006352195efc500",
  "selected_historical_source_sequence_length": 221,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 39,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/V9TS54.json",
  "source_sha256": "53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e",
  "retrieved_utc": "2026-11-01T06:25:30.137210+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"V9TS54\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/V9TS54.json",
  "source_sha256": "53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e",
  "retrieved_utc": "2026-11-01T06:25:30.137210+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":41,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2014-03-19\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/V9TS54.json",
  "source_sha256": "53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e",
  "retrieved_utc": "2026-11-01T06:25:30.137210+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Soft-rot fungus\",\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Sordariomycetidae\",\"Sordariales\",\"Chaetomiaceae\",\"Mycothermus\"],\"scientificName\":\"Humicola insolens\",\"taxonId\":85995}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/V9TS54.json",
  "source_sha256": "53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e",
  "retrieved_utc": "2026-11-01T06:25:30.137210+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"1,4-beta-D-xylan xylanohydrolase 11A\"}}],\"flag\":\"Precursor\",\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"24262572\",\"source\":\"PubMed\"}],\"value\":\"3.2.1.8\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"24262572\",\"source\":\"PubMed\"}],\"value\":\"Endo-1,4-beta-xylanase 11A\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"24262572\",\"source\":\"PubMed\"}],\"value\":\"Xylanase 11A\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/V9TS54.json",
  "source_sha256": "53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e",
  "retrieved_utc": "2026-11-01T06:25:30.137210+00:00",
  "json_pointer": "/comments/4",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000255\",\"id\":\"RU362015\",\"source\":\"RuleBase\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"24262572\",\"source\":\"PubMed\"}],\"value\":\"Glycan degradation; xylan degradation\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/V9TS54.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/V9TS54.json",
  "source_sha256": "53c73dbe7d403276bee2acc0f3aa08144adabd770e1e4b76b5d290b9edaa0a7e",
  "retrieved_utc": "2026-11-01T06:25:30.137210+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Yang X.\",\"Shi P.\",\"Huang H.\",\"Luo H.\",\"Wang Y.\",\"Zhang W.\",\"Yao B.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"24262572\"},{\"database\":\"DOI\",\"id\":\"10.1016/j.foodchem.2013.10.062\"}],\"citationType\":\"journal article\",\"firstPage\":\"381\",\"id\":\"24262572\",\"journal\":\"Food Chem.\",\"lastPage\":\"387\",\"publicationDate\":\"2014\",\"title\":\"Two xylose-tolerant GH43 bifunctional ?-xylosidase/?-arabinosidases and one GH11 xylanase from Humicola insolens and their synergy in the degradation of xylan.\",\"volume\":\"148\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"Y1\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [MRNA]\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"SUBSTRATE SPECIFICITY\",\"ACTIVITY REGULATION\",\"BIOTECHNOLOGY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/V9TS54?format=txt&versions=39)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/V9TS54?format=txt&versions=39",
  "source_sha256": "a074e123d2ec0589aa06f4931d85860d82aaf183072ecb88102fc2c6e967dd34",
  "retrieved_utc": "2026-11-01T06:28:53.416982+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   XY11A_HUMIN             Reviewed;         221 AA.\nAC   V9TS54;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   19-MAR-2014, sequence version 1.\nDT   18-JUN-2025, entry version 39.\nDE   RecName: Full=Endo-1,4-beta-xylanase 11A {ECO:0000303|PubMed:24262572};\nDE            Short=Xylanase 11A {ECO:0000303|PubMed:24262572};\nDE            EC=3.2.1.8 {ECO:0000269|PubMed:24262572};\nDE   AltName: Full=1,4-beta-D-xylan xylanohydrolase 11A {ECO:0000305};\nDE   Flags: Precursor;\nGN   Name=Xyn11A {ECO:0000303|PubMed:24262572};\nOS   Humicola insolens (Soft-rot fungus).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Sordariomycetidae; Sordariales; Chaetomiaceae; Mycothermus.\nOX   NCBI_TaxID=85995;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 39,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/V9TS54?format=txt&versions=39)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/V9TS54?format=txt&versions=39",
  "source_sha256": "a074e123d2ec0589aa06f4931d85860d82aaf183072ecb88102fc2c6e967dd34",
  "retrieved_utc": "2026-11-01T06:28:53.416982+00:00",
  "source_locator": "lines 16-26",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY,\nRP   BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY, ACTIVITY REGULATION,\nRP   AND BIOTECHNOLOGY.\nRC   STRAIN=Y1;\nRX   PubMed=24262572; DOI=10.1016/j.foodchem.2013.10.062;\nRA   Yang X., Shi P., Huang H., Luo H., Wang Y., Zhang W., Yao B.;\nRT   \"Two xylose-tolerant GH43 bifunctional ?-xylosidase/?-arabinosidases and\nRT   one GH11 xylanase from Humicola insolens and their synergy in the\nRT   degradation of xylan.\";\nRL   Food Chem. 148:381-387(2014).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 39,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/V9TS54?format=txt&versions=39)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/V9TS54?format=txt&versions=39",
  "source_sha256": "a074e123d2ec0589aa06f4931d85860d82aaf183072ecb88102fc2c6e967dd34",
  "retrieved_utc": "2026-11-01T06:28:53.416982+00:00",
  "source_locator": "lines 48-49",
  "excerpt": "CC   -!- PATHWAY: Glycan degradation; xylan degradation.\nCC       {ECO:0000255|RuleBase:RU362015, ECO:0000269|PubMed:24262572}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 39,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 89. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
